Form 4: HealthEquity Executive Michael Fiore Sells Shares Under 10b5-1 Trading Plan

Michael Fiore, EVP and Chief Commercial Officer of HealthEquity, Inc., sold 8,881 shares of common stock at a price of $78.2621 per share on April 4, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On April 4, 2025, Michael Fiore, the EVP and Chief Commercial Officer of HealthEquity, Inc. (HQY), sold 8,881 shares of the company's common stock.
• The sale was executed at a price of $78.2621 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 18, 2024.
• Following the transaction, Fiore directly owns 56,655 shares of HealthEquity, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an executive stock sale. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock sales are a common occurrence and are often part of pre-planned diversification strategies or to cover personal financial obligations. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sale by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

HealthEquity, Michael Fiore, stock sale, Form 4, 10b5-1 trading plan, executive, HQY, securities